INO logo

Inovio Pharmaceuticals, Inc.

INO
Healthcare|Biotechnology|US
$1.22
-0.23 (-16.21%)
DCF Value
$0.69
Tangible Book / Share
$0.05
Cash / Share
$0.45
Financing Filings (last 12 months)
10
Shelf registrations / offering prospectuses — latest Nov 6, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (2)

Dec 2026
Est. completion
P1BRCA1/2 Mutation
INO 5401 Vaccination in BRCA1/2 Mutation Carriers
NCT04367675n=44
Dec 2027
Est. completion
P1P2Glioblastoma
INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
NCT03491683n=52

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

Mar 2020
P1
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection
NCT02772003

Recent Press Releases

INOVIO Announces Pricing of Approximately $75 Million Public Offering
Nov 5, 2026 · PRNewsWire
INOVIO Announces Proposed Public Offering of its Common Stock
Nov 5, 2026 · PRNewsWire
INOVIO to Report Third Quarter 2026 Financial Results on November 10, 2026
Nov 2, 2026 · PRNewsWire
INOVIO to Participate in Upcoming Scientific Conferences
Nov 2, 2026 · PRNewsWire
INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP)
Oct 30, 2026 · PRNewsWire
INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science
Oct 20, 2026 · PRNewsWire
INOVIO to Participate in Upcoming Investor Conferences
Sep 1, 2026 · PRNewsWire
INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 12, 2026 · PRNewsWire

SEC Filings (74)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 2026424B5Offering prospectusDocumentIndex
Nov 6, 2026FWPDocumentIndex
Nov 5, 20268-KMaterial eventDocumentIndex
Nov 5, 2026424B5Offering prospectusDocumentIndex
Nov 5, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Nov 2, 20268-KMaterial eventDocumentIndex
Oct 6, 20268-KMaterial eventDocumentIndex
Aug 12, 20268-KMaterial eventDocumentIndex
Aug 12, 202610-QQuarterly reportDocumentIndex
Aug 12, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 7, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 6, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 31, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 31, 20268-KMaterial eventDocumentIndex
Jul 30, 2026424B5Offering prospectusDocumentIndex
Jul 29, 20268-KMaterial eventDocumentIndex
Jul 29, 2026424B5Offering prospectusDocumentIndex
Jul 10, 2026EFFECTDocumentIndex
Jul 2, 2026S-3Shelf registrationDocumentIndex
May 26, 2026S-8Employee stock planDocumentIndex
May 20, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 13, 20268-KMaterial eventDocumentIndex
May 13, 202610-QQuarterly reportDocumentIndex
May 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 6, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Apr 7, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 6, 20268-KMaterial eventDocumentIndex
Apr 2, 2026424B5Offering prospectusDocumentIndex
Apr 2, 20268-KMaterial eventDocumentIndex
Apr 2, 2026424B5Offering prospectusDocumentIndex
Mar 12, 20268-KMaterial eventDocumentIndex
Mar 12, 202610-KAnnual reportDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 30, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 27, 2026424B5Offering prospectusDocumentIndex
Jan 27, 20268-KMaterial eventDocumentIndex
Dec 29, 20258-KMaterial eventDocumentIndex
Dec 8, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Dec 5, 2025SC 13GPassive 5%+ stakeDocumentIndex